Rendering

Component: (Network and Table)
Network
126 - Disclosure - Stockholders' Equity (Deficit) (Tables)
(http://www.titanpharm.com/role/StockholdersEquityDeficitTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000910267 (http://www.sec.gov/CIK)
Stockholders' Deficit [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Stockholders' Deficit [Abstract]
 
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
As of December 31, 2016, warrants to purchase shares of common stock consisted of the following (in thousands, except per share price):
 
Date Issued
 
Expiration Date
 
Exercise Price
 
Outstanding at
December 31, 2016
 
04/13/2012
 
04/13/2018
 
$
4.89
 
 
983
 
10/08/2014
 
10/08/2020
 
$
3.30
 
 
848
 
 
 
 
 
 
 
 
 
1,831
 
  
Schedule Of Shares Reserved For Future Issuance [Table Text Block]
As of December 31, 2016, shares of common stock reserved by us for future issuance consisted of the following (in thousands):
 
Stock options outstanding
 
2,002
 
Shares issuable upon the exercise of warrants
 
1,831
 
 
 
3,833